Author

И. В. Губарева

Observed names: I Gubareva, I. Gubareva, I. V. Gubareva, I.V. Gubareva, Irina GUBAREVA, Irina Gubareva, Irina V Gubareva, Irina V. Gubareva, Irina V. Gubarevа, Irina Valer'evna Gubareva, Irina Valerievna Gubareva, Ирина Валерьевна Губарева

Institution: Samara State Medical University

Observed institution: Samara State Medical University

ORCID: 0000-0003-1881-024X

Observed ORCID: 0000-0003-1881-024X

OpenAlex ID: A5090867312

Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up

2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 60

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19

2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 55

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)

2021 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 26

Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)

2021 · E. I. Tarlovskaya, A. G. Arutyunov, et al. · Kardiologiia · 21

ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis

2022 · Gregory P. Arutyunov, Ekaterina I. Tarlovskaya, et al. · Terapevticheskii arkhiv · 17

Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAMMA (Clinical registry on patient population with polyvascular disease in the Russian Federation and Eurasian countries)

2024 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 13

International register “Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)”

2020 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Kardiologiia · 13

Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

2022 · G. P. Arutyunov, E. I Tarlovskaya, et al. · Russian Journal of Cardiology · 12

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients

2020 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 11

Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

2023 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 9

Lipid profile changes after the acute COVID-19 period. Sub-analysis of the International Registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV SARS-CoV-2)" (12-month follow-up)

2023 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 8

The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries

2023 · A. G. Arutyunov, E. I. Tarlovskaya, et al. · Problems of Endocrinology · 6

Proprotein convertase subtilisin kexin type 9 and main artery atherosclerosis in patients with arterial hypertension

2022 · Yulia VUKOLOVA, Irina GUBAREVA, et al. · Minerva Cardiology and Angiology · 5

Real-world data on managing patients with coronary artery disease and multifocal atherosclerosis. Results of the 12-month international clinical registry of patients with identified multifocal atherosclerosis in the Russian Federation and Eurasian countries (KAMMA)

2025 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 4

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"

2022 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Russian Journal of Cardiology · 4

Orthostatic hypertension in cardiovascular risk stratification in hypertensive patients

2021 · E. Yu. Gubareva, O. V. Fatenkov, et al. · Russian Journal of Cardiology · 4

Vascular endothelial growth factor as a potential marker of subclinical organ damage mediated by arterial hypertension

2019 · E. Yu. Gubareva, I. V. Gubareva · Сибирский журнал клинической и экспериментальной медицины · 4

Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries)

2024 · G. P. Arutyunov, E. I. Tarlovskaya, et al. · Kardiologiia · 3

Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)

2024 · M. M. Batyushin, M. A. Trubnikova, et al. · Russian Journal of Cardiology · 3

Анализ влияния коморбидной сердечно-сосудистой патологии на течение и исходы COVID-19 у госпитализированных пациентов в первую и вторую волну пандемии в Евразийском регионе

2022 · Григорий Павлович Арутюнов, Екатерина Иосифовна Тарловская, et al. · Kardiologiia · 3

Role of catestatin in development and decompensation of heart failure: a literature review

2021 · Yu. V. Meshcheryakov, I. V. Gubareva, et al. · Russian Journal of Cardiology · 3

Catestatin as a Novel Marker of Cardiovascular Risk in Systemic Hypertension

2018 · E. Yu. Gubareva, N. N. Kryukov, et al. · Russian Journal of Cardiology · 3

Strategies for choosing combination therapy for hypertension in metabolic syndrome - focus on inflammation

2024 · I. V. Gubareva, A. V. Pashentseva, et al. · Экспериментальная и клиническая гастроэнтерология · 2

Hypotension: diagnostic criteria, pathogenetic mechanisms, personalized approach to diagnosis and treatment (lecture)

2022 · E. Yu. Gubareva, D. V. Duplyakov, et al. · Russian Journal for Personalized Medicine · 2

Relationship of sortilin and proprotein convertase subtilisin/kexin type 9 in blood serum with the severity of carotid and coronary atherosclerosis in hypertensive patients

2022 · Yu. Yu. Vukolova, I. V. Gubareva · Russian Journal of Cardiology · 2

Works count: 58

Citation count: 306

H-index: 9

I10-index: 9